HNGE filing: Insight Venture lists Class A share sales

Hinge Health, Inc. (HNGE) filing a Form 144 reporting proposed sales of Class A common stock by Insight Venture Partners (Cayman) X, L.P.

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) filing a Form 144 reporting proposed sales of Class A common stock by Insight Venture Partners (Cayman) X, L.P. The excerpt lists multiple sale notices in June 2026, including 732,444 shares on 06/29/2026 and 266,290 shares on 06/24/2026.

The filing itemizes individual transfers with dollar values wired for each trade; sale dates shown range from 06/16/2026 through 06/29/2026. The document also references Series B Preferred converted before IPO and a prior wired transfer dated 07/03/2018.

Insights

Securities Counsel

Routine affiliate resale notices for Class A shares were filed; multiple dated transactions are listed.

The excerpt lists a series of proposed or reported sales by Insight Venture Partners (Cayman) X, L.P. with discrete share counts and wired proceeds per row. These entries align with Form 144’s role as a notice of proposed resale by an affiliate.

Timing and cash‑flow recipients are explicit per row (dates and wired amounts). Subsequent filings or broker reports would confirm actual settlement; this excerpt alone records the notice-level details.

Key Figures

Largest single entry: 732,444 shares Other notable entry: 266,290 shares Earlier June sale: 32,751 shares +3 more

6 metrics

Largest single entry 732,444 shares 06/29/2026 row showing wired proceeds

Other notable entry 266,290 shares 06/24/2026 row showing wired proceeds

Earlier June sale 32,751 shares 06/16/2026 row

Mid‑June sale 112,064 shares 06/22/2026 row

Series B Preferred conversion row 106,729 07/03/2018 labeled 'Stock Conversion before IPO'

Example wired proceeds (largest row) $60,670,973.32 Dollar amount paired with 732,444 shares on 06/29/2026

Key Terms

Form 144, Class A, Series B Preferred, Wired to portfolio company

4 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Class A financial

"Class A | Raymond James & Associates ... NYSE"

Class A denotes a specific group of a company’s shares that carry a particular set of rights—most commonly different voting power or dividend priority compared with other share classes. Think of it like different seats on a bus where some seats let you steer and others only ride: knowing whether a share is Class A tells investors how much influence they have over company decisions and how returns might be distributed, which affects control and value.

Series B Preferred financial

"Series B Preffered | 07/03/2018 | Stock Conversion before IPO"

Series B preferred is a class of ownership created during a later private funding round that gives investors special rights ahead of ordinary shareholders. Think of it like a priority ticket at a crowded exit: holders get paid or reimbursed before common shareholders if the company is sold or winds down, often receive fixed payments or protection against value loss, and typically have options to convert into regular shares; those features affect potential returns and control for investors.

Wired to portfolio company other

"07/03/2018 | Wired to portfolio company"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the HNGE Form 144 disclose?

The Form 144 lists proposed sales of Class A common stock by an affiliate. It shows multiple transactions dated 06/16/2026–06/29/2026 with share counts and wired dollar amounts for each row.

Who is the selling holder named in the HNGE excerpt?

The excerpt names Insight Venture Partners (Cayman) X, L.P. as the selling holder, with several separate sale notices and associated wired proceeds listed on specific June 2026 dates.

How many shares are listed in the largest entry?

The largest single entry in the excerpt is 732,444 shares reported on 06/29/2026, with an associated dollar amount shown in the same row.

Does the excerpt show proceeds or settlement details?

Yes; each row pairs a share count and a dollar value described as wired amounts (for example, $60,670,973.32 paired with 732,444 shares on 06/29/2026 in the excerpt).

Are there any historical convertible or preferred items noted?

The excerpt references a Series B Preferred entry dated 07/03/2018 described as Stock Conversion before IPO, with 106,729 shown in that row.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/07/2026 - 04:27 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001710959
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 MARKET STREET 7TH FLOOR SAN FRANCISCO CALIFORNIA 94105
Phone	415-689-8429
Name of Person for Whose Account the Securities are To Be Sold	Insight Venture Partners X, L.P.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	732444	65919960.00	54655926	07/07/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Series B Preffered	07/03/2018	Stock Conversion before IPO	Hinge Health, Inc.			106729	07/03/2018	Wired to portfolio company

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Insight Venture Partners (Cayman) X, L.P. 1114 Avenue of the Americas 36th Floor New York NY 10036	Class A	06/16/2026	32751	2304347.26
Insight Venture Partners (Cayman) X, L.P. 1114 Avenue of the Americas 36th Floor New York, NY 10036	Class A	06/22/2026	112064	7951400.26
Insight Venture Partners (Cayman) X, L.P. 1114 Avenue of the Americas 36th Floor New York NY 10036	Class A	06/23/2026	56171	3944018.68
Insight Venture Partners (Cayman) X, L.P 114 Avenue of the Americas 36th Floor New York NY 10036	Class A	06/24/2026	266290	18963363.03
nsight Venture Partners (Cayman) X, L.P 114 Avenue of the Americas 36th Floor New York NY 10036	Class A	06/25/2026	265169	19045365.67
nsight Venture Partners (Cayman) X, L.P 14 Avenue of the Americas 36th Floor New York NY 10036	Class A	06/29/2026	732444	60670973.32

144: Remarks and Signature

Remarks
Date of Notice	07/07/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Rashida Mitchell, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Insight Venture Partners (Cayman) X,
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)